These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 424435)

  • 21. Study of the nicotinic activity of very potent muscarinic agents.
    Lucchelli A; Boselli C; Grana E
    Farmaco Sci; 1986 Mar; 41(3):175-82. PubMed ID: 3486779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-allyl analogues of phencyclidine: chemical synthesis and pharmacological properties.
    Kalir A; Teomy S; Amir A; Fuchs P; Lee SA; Holsztynska EJ; Rocki W; Domino EF
    J Med Chem; 1984 Oct; 27(10):1267-71. PubMed ID: 6481761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.
    Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB
    Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities.
    Katz EJ; Cortes VI; Eldefrawi ME; Eldefrawi AT
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):227-36. PubMed ID: 9344890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
    Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
    Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
    Bhat RV; Turner SL; Marks MJ; Collins AC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
    Weiland GA; Durkin JA; Henley JM; Simasko SM
    Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
    Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
    J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.
    Brunner F; Kukovetz WR
    J Cardiovasc Pharmacol; 1986; 8(4):712-21. PubMed ID: 2427809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.
    Nilvebrant L; Sparf B
    Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors.
    Gabrielevitz A; Kloog Y; Kalir A; Balderman D; Sokolovsky M
    Life Sci; 1980 Jan; 26(2):89-95. PubMed ID: 7366325
    [No Abstract]   [Full Text] [Related]  

  • 37. On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs.
    Pinchasi I; Maayani S; Egozi Y; Sokolovsky M
    Psychopharmacology (Berl); 1978 Jan; 56(1):37-40. PubMed ID: 415324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the interaction of drugs with the cholinergic nervous system--III. Tolerance to phencyclidine derivatives: in vivo and in vitro studies.
    Pinchasi I; Maayani S; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1671-9. PubMed ID: 901586
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional evidence for a second binding site of nicotinic antagonists using phencyclidine derivatives.
    Kloog Y; Gabrialevitz A; Kalir A; Balderman D; Sokolovsky M
    Biochem Pharmacol; 1979 Apr; 28(8):1447-50. PubMed ID: 444312
    [No Abstract]   [Full Text] [Related]  

  • 40. Phencyclidine: behavioral and biochemical evidence against the anticholinergic hypothesis.
    Johnson KM
    Pharmacol Biochem Behav; 1982 Jul; 17(1):53-7. PubMed ID: 7122667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.